Youcef Mehellou

2.5k total citations
40 papers, 1.9k citations indexed

About

Youcef Mehellou is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Youcef Mehellou has authored 40 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 11 papers in Infectious Diseases and 8 papers in Organic Chemistry. Recurrent topics in Youcef Mehellou's work include HIV/AIDS drug development and treatment (11 papers), Biochemical and Molecular Research (10 papers) and Ion Transport and Channel Regulation (8 papers). Youcef Mehellou is often cited by papers focused on HIV/AIDS drug development and treatment (11 papers), Biochemical and Molecular Research (10 papers) and Ion Transport and Channel Regulation (8 papers). Youcef Mehellou collaborates with scholars based in United Kingdom, Belgium and United States. Youcef Mehellou's co-authors include Erik De Clercq, Jan Balzarini, Christopher McGuigan, Hachemi Kadri, Jan Balzarini, Dario R. Alessi, Mária Deák, Thomas Macartney, Frances‐Rose Schumacher and Thimo Kurz and has published in prestigious journals such as The EMBO Journal, Biochemical Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Youcef Mehellou

40 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youcef Mehellou United Kingdom 20 1.1k 567 485 283 225 40 1.9k
Soumya S. Ray United States 27 1.4k 1.3× 332 0.6× 145 0.3× 166 0.6× 236 1.0× 41 2.2k
Ganesha Rai United States 26 1.3k 1.2× 104 0.2× 311 0.6× 153 0.5× 72 0.3× 90 2.2k
Aiming Sun United States 29 947 0.9× 156 0.3× 401 0.8× 455 1.6× 84 0.4× 42 2.1k
Hideya Hayashi Japan 23 820 0.8× 210 0.4× 427 0.9× 85 0.3× 162 0.7× 70 1.8k
Yongseok Choi South Korea 22 566 0.5× 308 0.5× 392 0.8× 173 0.6× 93 0.4× 64 1.3k
Jim Zhen Wu United States 31 780 0.7× 409 0.7× 538 1.1× 518 1.8× 51 0.2× 50 2.1k
Valentina Molteni United States 23 663 0.6× 121 0.2× 675 1.4× 398 1.4× 114 0.5× 36 1.7k
Tove Tuntland United States 25 732 0.7× 151 0.3× 482 1.0× 142 0.5× 45 0.2× 39 1.7k
R. T. BORCHARDT United States 24 1.0k 0.9× 200 0.4× 183 0.4× 222 0.8× 47 0.2× 49 1.7k

Countries citing papers authored by Youcef Mehellou

Since Specialization
Citations

This map shows the geographic impact of Youcef Mehellou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youcef Mehellou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youcef Mehellou more than expected).

Fields of papers citing papers by Youcef Mehellou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youcef Mehellou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youcef Mehellou. The network helps show where Youcef Mehellou may publish in the future.

Co-authorship network of co-authors of Youcef Mehellou

This figure shows the co-authorship network connecting the top 25 collaborators of Youcef Mehellou. A scholar is included among the top collaborators of Youcef Mehellou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youcef Mehellou. Youcef Mehellou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tucker, James H. R., et al.. (2024). Phosphonodiamidate prodrugs of phosphoantigens (ProPAgens) exhibit potent Vγ9/Vδ2 T cell activation and eradication of cancer cells. RSC Medicinal Chemistry. 15(7). 2462–2473. 3 indexed citations
2.
Mehellou, Youcef. (2023). Parkinson’s Disease: Are PINK1 Activators Inching Closer to the Clinic?. ACS Medicinal Chemistry Letters. 14(7). 870–874. 8 indexed citations
3.
Elvers, Karen T, et al.. (2021). Structures of the Human SPAK and OSR1 Conserved C ‐Terminal (CCT) Domains**. ChemBioChem. 23(1). e202100441–e202100441. 3 indexed citations
4.
Grafton, Gillian, et al.. (2020). SPAK and OSR1 kinases bind and phosphorylate the β2-Adrenergic receptor. Biochemical and Biophysical Research Communications. 532(1). 88–93. 2 indexed citations
5.
Kadri, Hachemi, et al.. (2020). Aryloxy Triester Phosphoramidates as Phosphoserine Prodrugs: A Proof of Concept Study. ChemMedChem. 15(8). 671–674. 4 indexed citations
6.
Kadri, Hachemi, et al.. (2020). Aryloxy Diester Phosphonamidate Prodrugs of Phosphoantigens (ProPAgens) as Potent Activators of Vγ9/Vδ2 T-Cell Immune Responses. Journal of Medicinal Chemistry. 63(19). 11258–11270. 14 indexed citations
7.
Alamri, Mubarak A., Mark Jeeves, & Youcef Mehellou. (2019). Sequence specific assignment and determination of OSR1 C-terminal domain structure by NMR. Biochemical and Biophysical Research Communications. 512(2). 338–343. 4 indexed citations
8.
Mehellou, Youcef, et al.. (2018). C-terminal phosphorylation of SPAK and OSR1 kinases promotes their binding and activation by the scaffolding protein MO25. Biochemical and Biophysical Research Communications. 503(3). 1868–1873. 8 indexed citations
9.
Barini, Erica, Federico Tinarelli, Hachemi Kadri, et al.. (2017). The Anthelmintic Drug Niclosamide and Its Analogues Activate the Parkinson's Disease Associated Protein Kinase PINK1. ChemBioChem. 19(5). 425–429. 46 indexed citations
10.
Alamri, Mubarak A., Hachemi Kadri, Luke J. Alderwick, Nigel S. Simpkins, & Youcef Mehellou. (2017). Rafoxanide and Closantel Inhibit SPAK and OSR1 Kinases by Binding to a Highly Conserved Allosteric Site on Their C‐terminal Domains. ChemMedChem. 12(9). 639–645. 37 indexed citations
11.
Mehellou, Youcef. (2016). The ProTides Boom. ChemMedChem. 11(11). 1114–1116. 36 indexed citations
12.
Nguyen, Huy V., Antoine Sallustrau, Jan Balzarini, et al.. (2014). Organometallic Nucleoside Analogues with Ferrocenyl Linker Groups: Synthesis and Cancer Cell Line Studies. Journal of Medicinal Chemistry. 57(13). 5817–5822. 41 indexed citations
13.
Mehellou, Youcef, Dario R. Alessi, Thomas Macartney, et al.. (2013). Structural insights into the activation of MST3 by MO25. Biochemical and Biophysical Research Communications. 431(3). 604–609. 20 indexed citations
14.
Chen, Shengxi, et al.. (2012). Synthesis of pdCpAs and transfer RNAs activated with thiothreonine and derivatives. Bioorganic & Medicinal Chemistry. 20(8). 2679–2689. 9 indexed citations
15.
Filippi, B, Paola de los Heros, Youcef Mehellou, et al.. (2011). MO25 is a master regulator of SPAK/OSR1 and MST3/MST4/YSK1 protein kinases. The EMBO Journal. 30(9). 1730–1741. 112 indexed citations
16.
Thastrup, Jacob, Fatema H. Rafiqi, Alberto C. Vitari, et al.. (2011). SPAK/OSR1 regulate NKCC1 and WNK activity: analysis of WNK isoform interactions and activation by T-loop trans-autophosphorylation. Biochemical Journal. 441(1). 325–337. 105 indexed citations
17.
Mehellou, Youcef, Jan Balzarini, & Christopher McGuigan. (2010). The Design, Synthesis and Antiviral Evaluation of a Series of 5-trimethylsilyl-1-β-d-(arabinofuranosyl) uracil phosphoramidate ProTides. Antiviral chemistry & chemotherapy. 20(4). 153–160. 3 indexed citations
18.
Mehellou, Youcef, Jan Balzarini, & Christopher McGuigan. (2009). Aryloxy Phosphoramidate Triesters: a Technology for Delivering Monophosphorylated Nucleosides and Sugars into Cells. ChemMedChem. 4(11). 1779–1791. 182 indexed citations
19.
Mehellou, Youcef, Jan Balzarini, & Christopher McGuigan. (2009). An investigation into the anti-HIV activity of 2′,3′-didehydro-2′,3′-dideoxyuridine (d4U) and 2′,3′-dideoxyuridine (ddU) phosphoramidate ‘ProTide’ derivatives. Organic & Biomolecular Chemistry. 7(12). 2548–2548. 28 indexed citations
20.
Mehellou, Youcef, Christopher McGuigan, Andrea Brancale, & Jan Balzarini. (2007). Design, synthesis, and anti-HIV activity of 2′,3′-didehydro-2′,3′-dideoxyuridine (d4U), 2′,3′-dideoxyuridine (ddU) phosphoramidate ‘ProTide’ derivatives. Bioorganic & Medicinal Chemistry Letters. 17(13). 3666–3669. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Soumya S. Ray Breakdown of academic impact, for papers by Ganesha Rai Breakdown of academic impact, for papers by Aiming Sun Breakdown of academic impact, for papers by Hideya Hayashi Breakdown of academic impact, for papers by Yongseok Choi Breakdown of academic impact, for papers by Jim Zhen Wu Breakdown of academic impact, for papers by Valentina Molteni Breakdown of academic impact, for papers by Tove Tuntland Breakdown of academic impact, for papers by R. T. BORCHARDT
Rankless by CCL
2026